Fair Value of Assets and Liabilities (Tables)
|
3 Months Ended |
Mar. 28, 2026 |
| Fair Value Disclosures [Abstract] |
|
| Schedule of Derivative Instruments |
The trade entry date, maturity date, weighted-average floor, and weighted-average ceiling for each collar trade was as follows: | | | | | | | | | | | | | Trade Entry Date | Trade Maturity Date | Weighted-Average Floor | Weighted-Average Ceiling | | July 3, 2024 | August 29, 2025 | 18.0000 | 19.4350 | | August 5, 2024 | September 29, 2025 | 19.6550 | 21.0000 | | September 3, 2024 | November 3, 2025 | 20.0820 | 21.7571 | | September 30, 2024 | November 26, 2025 | 19.8700 | 21.3650 | | November 4, 2024 | January 2, 2026 | 20.1200 | 21.6900 | | December 3, 2024 | February 2, 2026 | 20.4250 | 22.0377 | | January 2, 2025 | March 2, 2026 | 20.8000 | 21.9082 | | February 6, 2025 | March 30, 2026 | 20.5300 | 22.0000 | | April 9, 2025 | June 1, 2026 | 20.9700 | 22.2355 | | May 1, 2025 | June 29, 2026 | 19.6940 | 20.9700 | | June 4, 2025 | August 3, 2026 | 19.3100 | 20.3437 | | July 2, 2025 | August 31, 2026 | 18.8500 | 19.8025 | | August 5, 2025 | September 29, 2026 | 18.8500 | 19.8000 | | September 2, 2025 | November 2, 2026 | 18.8100 | 19.8347 | | September 30, 2025 | November 30, 2026 | 18.4200 | 19.3700 | | November 4, 2025 | January 4, 2027 | 18.7200 | 19.7000 | | November 26, 2025 | February 2, 2027 | 18.4300 | 19.4852 | | January 6, 2026 | March 1, 2027 | 18.0620 | 18.9250 | | February 4, 2026 | April 5, 2027 | 17.4175 | 18.2500 | | March 4, 2026 | May 3, 2027 | 17.6720 | 18.4060 |
|
| Schedule of Derivative Instruments in Statement of Financial Position, Fair Value |
As of March 28, 2026 and December 27, 2025, the fair values of the Company's derivative financial instruments and their classifications on the Condensed Consolidated Balance Sheets were as follows:
| | | | | | | | | | | | | | | | | | | | (in thousands) | Condensed Consolidated Balance Sheets Classification | | March 28, 2026 | | December 27, 2025 | | | | Derivatives designated as hedging instruments | | | | | | | | | Interest rate swap agreement: | | | | | | | | | Designated as cash flow hedge | Prepaid expenses and other current assets | | $ | 1,714 | | | $ | 1,162 | | | | | Other long-term assets | | 618 | | | 382 | | | | | Zero cost collar agreement: | | | | | | | | | Designated as cash flow hedge | Prepaid expenses and other current assets | | $ | 3,602 | | | $ | 6,816 | | | | | Other long-term assets | | — | | | 3 | | | | | Accrued liabilities | | 777 | | | — | | | | | Other long-term liabilities | | 16 | | | — | | | | | Cross-currency swap agreement: | | | | | | | | | Designated as net investment hedge | Prepaid expenses and other current assets | | $ | 757 | | | $ | — | | | | | Other long-term assets | | 1,518 | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
| Schedule of Derivative Instruments Pre-tax Gains |
The pre-tax (gains) losses recognized on derivative financial instruments in the Condensed Consolidated Statements of Operations for the three months ended March 28, 2026 and March 29, 2025 were as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | | | (in thousands) | | Classification of (Gains) Losses Recognized in the Condensed Consolidated Statements of Operations | | March 28, 2026 | | March 29, 2025 | | | | | | Derivatives designated as cash flow hedges | | | | | | | | | | | | Interest rate swap agreement | | Interest expense | | $ | (464) | | | $ | (788) | | | | | | | Zero cost collar agreement | | Cost of sales | | (4,078) | | | 1,480 | | | | | | | Zero cost collar agreement | | Selling, general, and administrative expenses | | (336) | | | 121 | | | | | | | Derivatives designated as net investment hedges | | | | | | | | | | | | Cross-currency swap agreement | | Interest expense | | $ | (97) | | | $ | — | | | | | |
The pre-tax (gains) losses recognized on derivative financial instruments in the Condensed Consolidated Statements of Comprehensive Income for the three months ended March 28, 2026 and March 29, 2025 were as follows:
| | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | | | (in thousands) | | March 28, 2026 | | March 29, 2025 | | | | | | Derivatives designated as cash flow hedges | | | | | | | | | | Interest rate swap agreement | | $ | (788) | | | $ | 2,318 | | | | | | | Zero cost collar agreement | | 4,031 | | | (2,442) | | | | | | | Derivatives designated as net investment hedges | | | | | | | | | | Cross-currency swap agreement | | $ | (2,275) | | | $ | — | | | | | |
|
| Schedule of Fair Value, Assets Measured on Recurring Basis |
The following table presents assets measured at fair value by classification within the fair value hierarchy as of March 28, 2026: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Fair Value Measurements Using | | | | (in thousands) | | Quoted Prices in Active Markets for Identical Assets (Level 1) | | Significant Other Observable Inputs (Level 2) | | Significant Unobservable Inputs (Level 3) | | Total | | Cash equivalents | | $ | 430,054 | | | $ | — | | | $ | — | | | $ | 430,054 | | | Investments in equity securities | | 7,396 | | | — | | | — | | | 7,396 | | | Mutual funds | | 26,150 | | | — | | | — | | | 26,150 | | | Total | | $ | 463,600 | | | $ | — | | | $ | — | | | $ | 463,600 | |
The following table presents assets measured at fair value by classification within the fair value hierarchy as of December 27, 2025: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Fair Value Measurements Using | | | | (in thousands) | | Quoted Prices in Active Markets for Identical Assets (Level 1) | | Significant Other Observable Inputs (Level 2) | | Significant Unobservable Inputs (Level 3) | | Total | | Cash equivalents | | $ | 465,915 | | | $ | — | | | $ | — | | | $ | 465,915 | | | Investments in equity securities | | 7,676 | | | — | | | — | | | 7,676 | | | Mutual funds | | 25,730 | | | — | | | — | | | 25,730 | | | Total | | $ | 499,321 | | | $ | — | | | $ | — | | | $ | 499,321 | |
|
| Schedule of Fair Value, by Balance Sheet Grouping |
The carrying value and estimated fair values of the Company’s Euro Senior Notes, Series B and USD Senior Notes, Series B, as of March 28, 2026 and December 27, 2025 were as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | March 28, 2026 | | December 27, 2025 | | (in thousands) | | Carrying Value | | Estimated Fair Value | | Carrying Value | | Estimated Fair Value | | | | | | | | | | | Euro Senior Notes, Series B due 2028 | | $ | 109,545 | | | $ | 103,634 | | | $ | 111,977 | | | $ | 106,908 | | | | | | | | | | | | | | | | | | | | | USD Senior Notes, Series B due 2027 | | 100,000 | | | 99,132 | | | 100,000 | | | 99,152 | | | USD Senior Notes, Series B due 2030 | | 125,000 | | | 119,169 | | | 125,000 | | | 120,076 | | | USD Senior Notes, due 2032 | | 100,000 | | | 94,340 | | | 100,000 | | | 95,587 | |
|